Future studies using patient-derived α-synuclein conformers in more disease-relevant cell types may reveal potential disease-specific members of the proteostasis network that influence the seeded aggregation of α-Syn, which could explain the heterogeneity of synucleinopathies and pave the way toward disease-specific therapeutics3. Here, SNCA is linked to synucleinopathy.